Regeneron to Showcase Progress from Innovative Oncology - GlobeNewswire

Retrieved on: 2023-10-15 22:11:08

Tags for this article:

Cancer immunotherapy

Breakthrough therapy

Regeneron Pharmaceuticals

Non-small-cell lung cancer

Squamous-cell carcinoma

Ovarian cancer

PD-1 and PD-L1 inhibitors

Libtayo

Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

Regeneron to Showcase Progress from Innovative Oncology - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2023/10/15/2760264/0/en/Regeneron-to-Showcase-Progress-from-Innovative-Oncology-Portfolio-in-Several-Difficult-to-Treat-Cancers-at-ESMO.html

Excerpt

“Our data presentations at ESMO underscore Regeneron's ability to apply a deep understanding of cancer biology, genetics and the immune system to ...

Article found on: www.globenewswire.com

View Original Article